Oct 2026· Journal of Cancer Biomoleculars and Therapeutics· 0 citations
TL;DR
This narrative review critically evaluates how extracellular matrix stiffness, solid stress, interstitial fluid pressure, and fluid shear stress influence invasion, metastasis, and therapeutic resistance and compares their biological consequences and measurement approaches.
Abstract
Genetic alterations and biochemical signaling are central to malignant transformation; however, biomechanical cues within the tumor microenvironment (TME) also shape tumor behavior and treatment response. This narrative review critically evaluates how extracellular matrix (ECM) stiffness, solid stress, interstitial fluid pressure, and fluid shear stress influence invasion, metastasis, and therapeutic resistance. These cues engage integrin-focal adhesion kinase (FAK) signaling, RhoA-ROCK-dependent cytoskeletal tension, and the mechanosensitive transcriptional co-activators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ). We discuss how these routes interact with Wnt/β-catenin and transforming growth factor-β (TGF-β)/SMAD signaling, and how their effects depend on tumor type, matrix architecture, and disease stage. Rather than treating stiffness, solid stress, and fluid pressure as interchangeable, we compare their biological consequences and measurement approaches. We also assess the strengths and limitations of microfluidic and organ-on-chip platforms, elastography, and ex vivo nanomechanical assays. ECM-directed remodeling, mechanical decompression, and pathway inhibition offer complementary treatment strategies, but variable clinical efficacy, off-target effects, and biomarker standardization remain significant barriers. Integrating spatially resolved biomechanical measurements with molecular profiling may improve patient stratification and guide rational combination therapies.
The extracellular matrix (ECM) stiffening in the tumor microenvironment (TME) is an important physical characteristic of solid tumors and can serve as an active signaling hub that regulates the biological behavior of tumors. Abnormal deposition, cross-linking, and remodeling of collagen not only alter the mechanical pr...
Xiao-Lin Liu, Ying Wang, Fei Qi et al.· Technology in Cancer Researc...· 0 citations
Tumors progress within a mechanically dynamic tumor microenvironment (TME), where extracellular matrix (ECM) stiffening, solid stress, and elevated interstitial fluid pressure remodel tumor cell and tumor-associated cell behavior. This TME-related mechanical remodeling often leads to tumor progression, metastasis and t...
R. Luha, G. Sankar, Siddhesh Saigaonkar et al.· Seminars in Cancer Biology· 0 citations
An aberrant mechanical microenvironment is a major driver of malignant tumor progression. Its effects are not limited to the immediate regulation of tumor cell behavior. Through mechanotransduction-mediated epigenetic remodeling, external physical cues can also be converted into persistent malignant programs. Mechanica...
Ya-Hui Fu, Jing-Yang Liu, Zi-Cheng Guo et al.· Cancer Letters· 0 citations
Abstract The mechanosensitive ion channel Piezo1 translates physical cues from the tumor microenvironment—including extracellular matrix stiffness, fluid shear stress, and compressive forces—into intracellular calcium signals and downstream cascades, playing a pivotal role in cancer. Piezo1 exhibits pronounced tumor-ty...
Hai-Yan Jiang, Ying Liu, Fei Xue et al.· Drug Design, Development and...· 0 citations
By shifting from single-parameter modeling to systems-level reconstruction of the TMME, tumor organoid models are becoming increasingly powerful platforms for mechanistic discovery and therapeutic evaluation.
Shu-Ying Yan, Jing Zhu, J. Oliveira et al.· International Journal of Med...· 0 citations
Solid tumor progression is associated with several mechanical changes, including compression inside the tumor and stiffening and tension at the tumor edge and in the tumor-adjacent stroma. Mechanical remodeling of the extracellular matrix is an active driver of therapeutic resistance and metastatic potential. As such,...
Keefer Boone, Raghu Vamsi Kondapaneni, Sarah Libring et al.· Cancer Letters· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.